Altasciences’ CEO Chris Perkin Recognized as PharmaVoice Red Jacket Honoree
Laval, Québec, August 12, 2019 – Altasciences is proud to announce that CEO Chris Perkin has been recognized as a 2019 Red Jacket honoree. The Red Jacket Award was introduced by PharmaVOICE in 2014 to honor a select and distinguished group of leaders who have been lauded by their colleagues and peers numerous times as PharmaVOICE 100 designees for their many contributions to their companies and the industry at large. Chris has been a PharmaVOICE 100 designee every year since 2015, and, as a Red Jacket honoree, will be retiring the annual award for the lifetime achievement of the Red Jacket.
PharmaVOICE Red Jacket honorees:
- Challenge us to think differently, act differently, and lead differently
- Create opportunities to make what was once impossible — possible
- Are focused beyond short-term gains and are committed to executing their long-term visions in a tightly regulated and competitive industry
- Have a persistence of vision
- Are truly transforming the life sciences industry to create better health outcomes for all
- Are inspired leaders for today and tomorrow
Throughout Chris’ career, he has demonstrated a commitment to innovation, transformation, mentorship, and philanthropy. His entrepreneurial spirit and leadership have inspired Altasciences’ employees, peers, and company, and his influence is impacting the larger sphere of the life sciences industry.
“I am honored to have been selected for this recognition, which would have been impossible without the unwavering support of the Altasciences team, our sponsors, and key collaborators. I know that, working together, we can continue making positive impacts in the ever-evolving, fast-paced life sciences marketplace,” said Chris Perkin, CEO of Altasciences and Red Jacket honoree.
Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.